Quantcast

Latest Drug Development Stories

2014-10-23 04:21:52

BARCELONA, Spain, October 23, 2014 /PRNewswire/ -- Clients benefit from complete access, visibility, and control throughout the clinical trial inVentiv Health Clinical, a leading global supplier of drug development services, will replace its electronic trial master file (eTMF) content management system with Veeva Vault eTMF. Cloud-based, multitenant Vault eTMF delivers secure, instant access to inspection-ready documentation...

2014-10-20 08:32:09

NEW YORK and RALEIGH, N.C., Oct. 20, 2014 /PRNewswire/ -- BioPontis Alliance for Rare Disease and the Hereditary Neuropathy Foundation (HNF), both philanthropies, announced today the creation of a joint venture to develop drug candidates for the treatment of the rare disease known as Charcot- Marie-Tooth (CMT) Disease. http://photos.prnewswire.com/prnvar/20141019/152981LOGO BioPontis Alliance announced its alliance model earlier this month. Today's partnership announcement with HNF...

2014-10-17 08:25:37

PRINCETON, N.J., Oct. 17, 2014 /PRNewswire/ -- Covance (NYSE: CVD), the world's most comprehensive drug development company and a leader in nutritional analysis, today announced that it has been awarded the 2014 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award, based on the company's strong business performance and continued investments in the Asia Pacific region. The award was presented to Covance at the Frost & Sullivan Asia Pacific Best Practice Awards...

2014-10-14 08:31:11

BOSTON, Oct. 14, 2014 /PRNewswire/ -- Boston Strategics Corporation (BSC), an integrated clinical-stage drug research and development (R&D) company, Boston, MA, today announced that it has entered into an agreement with Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics. In collaboration with MRL, BSC designs and manages for pharmaceutical drug development programs to...

2014-10-09 23:06:16

Provectus Biopharmaceuticals Collaborates with ERT’s COA Experts to Understand Patient Perspective during Melanoma Drug Development PHILADELPHIA, PA (PRWEB) October 09, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced that Provectus Biopharmaceuticals (NYSE MKT: PVCT) is collaborating with ERT’s Clinical Outcome Assessment (COA) consultants on their Phase III trial of agent PV-10 for intralesional (IL)...

2014-10-02 23:09:49

Industry Leaders Share Best Practices Through Case Studies and Strategic Discussions Sunnyvale, CA (PRWEB) October 02, 2014 Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced highlights of its European Summit, held September 23 - 24, 2014 at GlaxoSmithKline (GSK) in Ware, UK. The meeting featured customer case studies and discussions of best practices in high throughput research and data management. At this...

2014-10-02 08:29:17

SAN DIEGO, Oct. 2, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, announced today that Edwin L. Parsley, D.O. has joined the Company as its Chief Medical Officer and Senior Vice President. Dr. Parsley has been actively engaged with the Company since it acquired Aires Pharmaceuticals, Inc. in February 2014. He has served as Mast's interim Chief Medical Officer since September 2014 and as Chief Medical Officer of Aires since...

2014-09-30 23:22:37

In a recent online interview by the Pharma IQ Division of the International Quality & Productivity Center (IQPC), James L. Sherley, M.D., Ph.D., the Director of the Adult Stem Cell Technology Center, LLC (ASCTC) discussed the state of technology for drug evaluations for stem cell toxicity. As an expert on the topic, Dr. Sherley emphasized that, currently, few technologies exist for screening-out drug candidates that will ultimately fail as medicines due to toxicity against stem cells...

2014-09-26 08:25:19

DUBLIN, Sept. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental...

2014-09-25 23:10:50

A year after its formation in September 2013, Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) was invited to present its commercialization plans and progress at the 7th Annual BioPharm America™ International Partnering Conference held in Boston from September 22-24. Over the three-day conference, the ASCTC presented to pharmaceutical executives and pharmaceutical investors its one-of-a-kind technologies poised to revolutionize stem cell medicine. Boston, Massachusetts (PRWEB)...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin